Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Cheelcare Inc. is a publicly traded company quoted on the U.S. OTC Markets under the ticker CHCRF. Based on available public disclosures and market records, the company is associated with the healthcare services and elder care industry, with a stated focus on providing senior care–related services and healthcare solutions. Publicly available information indicates that the company’s activities are oriented toward addressing the needs of aging populations, though the exact scope and scale of its operations are not comprehensively detailed in recent filings.
The company’s history and corporate evolution are only partially documented in accessible public sources. Available records indicate that Cheelcare Inc. has undergone name and strategic changes over time, which is not uncommon among small-cap and OTC-listed companies. However, detailed historical milestones, founding dates, and a clearly articulated long-term strategic narrative cannot be consistently verified across multiple independent sources. Data inconclusive based on available public sources.
Business Operations
Based on company disclosures and market data, Cheelcare Inc. appears to operate primarily through healthcare and senior-care–related business activities, which may include management services, consulting, or technology-enabled healthcare solutions. Revenue generation mechanisms are not clearly broken out into formally reported operating segments in recent publicly available filings, and there is no consistent disclosure of audited segment-level financial performance.
Information regarding proprietary technologies, owned healthcare assets, or clearly defined service platforms is limited. Public sources do not consistently identify material subsidiaries, joint ventures, or long-standing strategic partnerships. As a result, while the company is generally categorized within healthcare and elder care services, the operational structure and revenue drivers cannot be fully verified. Data inconclusive based on available public sources.
Strategic Position & Investments
Publicly available information suggests that Cheelcare Inc. has positioned itself to participate in long-term demographic trends related to aging populations and increased demand for healthcare and senior services. Strategic intent appears to emphasize participation in healthcare-related service markets rather than capital-intensive clinical operations, although this positioning is not supported by detailed strategic roadmaps in recent filings.
There is no consistently verified public record of significant acquisitions, major capital investments, or ownership of notable subsidiaries or portfolio companies. Likewise, involvement in emerging healthcare technologies or large-scale digital health platforms cannot be confirmed through multiple independent sources. Data inconclusive based on available public sources.
Geographic Footprint
Cheelcare Inc. is listed in the United States via the OTC Markets, but public disclosures suggest that its operational focus may be primarily outside the U.S., potentially in Asia, including China, where demographic trends support elder care demand. However, the company does not consistently report detailed geographic revenue breakdowns or operational footprints in publicly accessible filings.
Headquarters location, scale of international operations, and the extent of cross-border investments are not clearly disclosed in a manner that can be independently verified through multiple reputable sources. As such, while the company is often associated with Asian healthcare markets, the precise geographic scope of its operations remains unclear. Data inconclusive based on available public sources.
Leadership & Governance
Public filings and market disclosures provide limited, and sometimes outdated, information regarding the leadership and governance structure of Cheelcare Inc. While the company is required to maintain executive officers and a board of directors, detailed and current biographical information on leadership is not consistently available across multiple reputable sources.
Reported executive information varies by source and reporting period, and no stable, well-documented leadership team can be verified with confidence at present. As a result, the company’s leadership philosophy, governance practices, and strategic vision are not clearly articulated in the public domain. Data inconclusive based on available public sources.